Founded in 2014, Varocto Inc. is an ophthalmic research and development company located in the City of Orange, California. Varocto is a spin-off of Alfred E. Mann Institute at USC. We are developing the next generation non-invasive retinal vascular screening machine utilizing OCT (Optical Coherence Tomography) and OCTA (Optical Coherence Tomographic Angiography). OCT angiography is a non-invasive new technology to image the three dimensional vasculature of the eye without requiring pupil dilation and without any injection of dye. For many eye diseases including diabetes and age-related macular degeneration, non-invasive screening for the occurrence of retinal vascular problems before vision has been damaged has the potential to improve overall eye health.
This gallery of images was produced from data acquired from multiple development machines and processed using our proprietary OCT angiography algorithm. Images courtesy of Varocto, California Institute of Technology, University of Southern California, and University of California Davis.